CAS: 147663-04-5; 3-(2-(4-(6-Fluorobenzo[d]Isoxazol-3-yl)Piperidin-1-yl)Ethyl)-7-Hydroxy-2-Methyl-6,7,8,9-Tetrahydro-4H-Pyrido[1,2-A]Pyrimidin-4-One

结构式图片

上下游产品

3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-7-methoxy-2-methyl-4H-pyrido[1,2-a]-pyrimidin-4-one chloroform

合成工艺路线路线简述

    📜3-[2-[4-(6-氟-1,2-苯并异恶唑-3-基)-1-哌啶基]乙基]-6,7,8,9-四氢-7-甲氧基-2-甲基-4H-吡啶并[1,2-A]嘧啶-4-酮,碘代三甲硅烷置于sodium Hydroxide,氯仿,Silica Gel,甲醇体系中,用 乙腈 用作溶剂,化学反应 32.0H,以yielding 0.3 Parts (3.7%) Of 3-[2-[4-(6-Fluoro-1,2-Benzisoxazol-3-yl)-1-Piperidinyl]Ethyl]-6,7,8,9-Tetrahydro-7-Hydroxy-2-Methyl-4H-Pyrido[1,2-A]-Pyrimidin-4-One的收率获得7-羟基利培酮
    参考文献:3-[2-[4-(6-Fluoro-1,2-Benzisoxozol-3-yl)-1-Piperidinyl]Ethyl]-6,7,8,9
    标题:3-[2-[4-(6-Fluoro-1,2-Benzisoxozol-3-yl)-1-Piperidinyl]Ethyl]-6,7,8,9
    摘要:本发明涉及一种新型3-哌啶基-1,2-苯并异噁唑具有长效抗精神病特性,适用于治疗患有精神疾病的温血动物.本发明还涉及制备该化合物的方法和含有该化合物的组合物.

    海关参考信息

    专利信息


    专利号:US-9012648-B2
    优先权日:2012-08-21
    标题 :Haptens of risperidone and paliperidone
    发明人:HASPESLAGH PIETER RIK; VLIEGEN MAARTEN; HRYHORENKO ERIC; DECORY THOMAS R; SANKARAN BANUMATHI
    权利人:JANSSEN PHARMACEUTICA NV; ORTHO CLINICAL DIAGNOSTICS INC
    摘要:The invention relates to compounds of Formula I, wherein R1 and R2 are defined in the specification, useful for the synthesis of novel conjugates and immunogens derived from risperidone and paliperidone. The invention also relates to conjugates of a risperidone or paliperidone hapten and a protein.

    专利号:US-9394354-B2
    优先权日:2012-08-21
    标题 :Haptens of paliperidone
    发明人:HASPESLAGH PIETER RIK; VLIEGEN MAARTEN; HRYHORENKO ERIC; DECORY THOMAS R; SANKARAN BANUMATHI
    权利人:JANSSEN PHARMACEUTICA NV; ORTHO CLINICAL DIAGNOSTICS INC
    摘要:The invention relates to compounds of Formula I, wherein L 1 , L 2 , and L 3 are defined in the specification, useful for the synthesis of novel conjugates and immunogens derived from paliperidone. The invention also relates to conjugates of a paliperidone hapten and a protein.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知